Skip to main navigation Skip to search Skip to main content

MLIP and Its Potential Influence on Key Oncogenic Pathways

  • Mahmoud N. Hamwi
  • , Engy Elsayed
  • , Hanan Dabash
  • , Amani Abuawad
  • , Noor A. Aweer
  • , Faissal Al Zeir
  • , Shona Pedersen
  • , Layla Al-Mansoori
  • , Patrick G. Burgon

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)
6 Downloads (Pure)

Abstract

Muscle-enriched A-type lamin-interacting protein (MLIP) is an emerging protein involved in cellular homeostasis and stress adaptation. Eukaryotic cells regulate various cellular processes, including metabolism, DNA repair, and cell cycle progression, to maintain cellular homeostasis. Disruptions in this homeostasis can lead to diseases such as cancer, characterized by uncontrolled cell growth and division. This review aims to explore for the first time the unique role MLIP may play in cancer development and progression, given its interactions with the PI3K/Akt/mTOR pathway, p53, MAPK9, and FOXO transcription factors, all critical regulators of cellular homeostasis and tumor suppression. We discuss the current understanding of MLIP’s involvement in pro-survival pathways and its potential implications in cancer cells’ metabolic remodeling and dysregulated homeostasis. Additionally, we examine the potential of MLIP as a novel therapeutic target for cancer treatment. This review aims to shed light on MLIP’s potential impact on cancer biology and contribute to developing innovative therapeutic strategies.

Original languageEnglish
Article number1109
Number of pages16
JournalCells
Volume13
Issue number13
DOIs
Publication statusPublished - 1 Jul 2024
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Akt
  • cancer
  • MLIP
  • mTOR
  • PI3 kinase
  • tumorigenesis

Fingerprint

Dive into the research topics of 'MLIP and Its Potential Influence on Key Oncogenic Pathways'. Together they form a unique fingerprint.

Cite this